Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy

Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer immunity, which may result in immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Tianyu, Huang, Xing, Zhang, Gang, Hong, Zhengtao, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896069/
https://www.ncbi.nlm.nih.gov/pubmed/33608497
http://dx.doi.org/10.1038/s41392-020-00449-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896069/
https://www.ncbi.nlm.nih.gov/pubmed/33608497
http://dx.doi.org/10.1038/s41392-020-00449-4

Ejemplares similares